Table 5.

Serum BUN, creatinine, ALT, AST, ALP, bilirubin and TLC levels

Parameters	Treatment	Placebo (mean±SD)	Treatment (mean±SD)	Statistical analyses
BUN (mg/dL)	Baseline	25.79±7.15	26.16±8.62	t=0.274, p=0.784, ns
	On completion	25.24±8.05	24.45±5.89	t=0.651, p=0.516, ns
Creatinine (mg/dL)	Baseline	0.80±0.17	0.83±0.26	t=0.888, p=0.376, ns
	On completion	0.79±0.18	0.75±0.17	t=1.389, p=0.167, ns
ALT (U/L)	Baseline	43.41±28.42	38.31±20.65	t=1.195, p=0.234 ns
	On completion	31.96±14.82	32.23±13.52	t=0.108, p=0.914, ns
AST (U/L)	Baseline	34.59±17.48	34.09±21.79	t=0.149, p=0.882, ns
	On completion	27.03±8.04	28.76±15.62	t=0.830, p=0.408, ns
ALP (U/L)	Baseline	107.35±31.96	106.14±48.02	t=0.177, p=0.860, ns
	On completion	95.04±30.29	93.35±30.29	t=0.327, p=0.744, ns
Bilirubin (mg/dL)	Baseline	0.55±0.25	0.53±0.29	t=0.439, p=0.661, ns
	On completion	0.58±0.59	0.47±0.18	t=1.383, p=0.169, ns
Hb (%)	Baseline	13.47±1.53	13.76±1.78	t=1.031, p=0.304, ns
	On completion	13.75±1.66	14.02±1.69	t=0.956, p=0.341, ns
TLC (× 103/µL)	Baseline	2962.87±4149.82	2721.77±4139.51	t=0.341, p=0.733, ns
	On completion	2718.45±3784.73	2358.19±3562.91	t=0.574, p=0.567, ns

Data are expressed as mean±SD; ns, not significant.